Conversely, trans-chalcone significantly (P < 0.001) inhibited HFD-induced changes in HOMA-IR score and serum levels of liver injury markers (ALP, AST, and ALT) in rats of NASH + Chal group compared with the NASH group (Table 2). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.